YUNGJIN PHARM. CO., LTD
003520 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003520004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층, 송파구
- Website:
- https://eng.yungjin.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-28 00:00 |
Regulatory Filings
대규모기업집단현황공시[분기별공시(개별회사용)]
|
Korean | 6.1 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-08-14 00:00 |
Quarterly Report
[기재정정]분기보고서 (2025.03)
|
Korean | 695.0 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 879.7 KB | ||
| 2025-08-13 00:00 |
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
|
Korean | 11.1 KB | ||
| 2025-08-01 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-31 00:00 |
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 12.9 KB | ||
| 2025-07-25 00:00 |
Share Issue/Capital Change
[기재정정]신규시설투자등
|
Korean | 13.7 KB | ||
| 2025-05-30 00:00 |
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
|
Korean | 90.6 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 681.6 KB | ||
| 2025-05-07 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 33.7 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.7 KB | ||
| 2025-03-20 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.2 MB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 492.1 KB |
Automate Your Workflow. Get a real-time feed of all YUNGJIN PHARM. CO., LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for YUNGJIN PHARM. CO., LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for YUNGJIN PHARM. CO., LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France
ALDVI
France
ALDVI
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden
AEGIR
Sweden
AEGIR
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France
AELIS
France
AELIS
Developing therapeutic neurotoxins for medical conditions like migraines and cervical dystonia.
United States of America
AEON
United States of America
AEON
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan
2927
Japan
2927
Develops antibodies, cell therapies & adjuvants to harness the immune system against cancer.
United States of America
AGEN
United States of America
AGEN
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
United States of America
AGIO
United States of America
AGIO
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America
AKTX
United States of America
AKTX
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America
AKBA
United States of America
AKBA